Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Functional and structural insight into properdin control of complement alternative pathway amplification.

Pedersen DV, Roumenina L, Jensen RK, Gadeberg TA, Marinozzi C, Picard C, Rybkine T, Thiel S, Sørensen UB, Stover C, Fremeaux-Bacchi V, Andersen GR.

EMBO J. 2017 Apr 13;36(8):1084-1099. doi: 10.15252/embj.201696173. Epub 2017 Mar 6.

2.

A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H.

Chauvet S, Roumenina LT, Bruneau S, Marinozzi MC, Rybkine T, Schramm EC, Java A, Atkinson JP, Aldigier JC, Bridoux F, Touchard G, Fremeaux-Bacchi V.

J Am Soc Nephrol. 2016 Jun;27(6):1665-77. doi: 10.1681/ASN.2015040348. Epub 2015 Oct 15.

3.

Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome.

Schramm EC, Roumenina LT, Rybkine T, Chauvet S, Vieira-Martins P, Hue C, Maga T, Valoti E, Wilson V, Jokiranta S, Smith RJ, Noris M, Goodship T, Atkinson JP, Fremeaux-Bacchi V.

Blood. 2015 Apr 9;125(15):2359-69. doi: 10.1182/blood-2014-10-609073. Epub 2015 Jan 21.

4.

Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?

Marinozzi MC, Vergoz L, Rybkine T, Ngo S, Bettoni S, Pashov A, Cayla M, Tabarin F, Jablonski M, Hue C, Smith RJ, Noris M, Halbwachs-Mecarelli L, Donadelli R, Fremeaux-Bacchi V, Roumenina LT.

J Am Soc Nephrol. 2014 Sep;25(9):2053-65. doi: 10.1681/ASN.2013070796. Epub 2014 Mar 20.

5.

Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.

Békássy ZD, Kristoffersson AC, Cronqvist M, Roumenina LT, Rybkine T, Vergoz L, Hue C, Fremeaux-Bacchi V, Karpman D.

Nephrol Dial Transplant. 2013 Nov;28(11):2899-907. doi: 10.1093/ndt/gft340. Epub 2013 Sep 5.

PMID:
24009284
6.

An unusual primary sigma factor in the Bacteroidetes phylum.

Vingadassalom D, Kolb A, Mayer C, Rybkine T, Collatz E, Podglajen I.

Mol Microbiol. 2005 May;56(4):888-902.

7.

Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.

Pernot L, Frénois F, Rybkine T, L'Hermite G, Petrella S, Delettré J, Jarlier V, Collatz E, Sougakoff W.

J Mol Biol. 2001 Jul 20;310(4):859-74.

PMID:
11453693
8.

Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of beta-lactam resistance.

Rybkine T, Mainardi JL, Sougakoff W, Collatz E, Gutmann L.

J Infect Dis. 1998 Jul;178(1):159-63.

PMID:
9652435
9.

Increase of bradykinin-stimulated arachidonic acid release in a delta F508 cystic fibrosis epithelial cell line.

Levistre R, Lemnaouar M, Rybkine T, Béréziat G, Masliah J.

Biochim Biophys Acta. 1993 Jun 19;1181(3):233-9.

PMID:
7686400
10.

Type II phospholipase A2 recombinant overexpression enhances stimulated arachidonic acid release.

Pernas P, Masliah J, Olivier JL, Salvat C, Rybkine T, Bereziat G.

Biochem Biophys Res Commun. 1991 Aug 15;178(3):1298-305.

PMID:
1872850
11.

Partial apolipoprotein E-beta-galactosidase fusion protein expressed in Escherichia coli retains binding activity to the LDL(B/E) receptor.

Ribeiro A, Cardot P, Benarous R, Pernas P, Pepin D, Rybkine T, Chambaz J, Bereziat G.

Biochim Biophys Acta. 1990 Oct 23;1087(2):219-25.

PMID:
2223883
13.

Antigenic relatedness between phospholipases A2 from Naja naja venom and from mammalian cells.

Masliah J, Kadiri C, Pepin D, Rybkine T, Etienne J, Chambaz J, Bereziat G.

FEBS Lett. 1987 Sep 28;222(1):11-6.

14.

Arachidonic acid transfer from diacyl-sn-glycero-3-phosphocholine to ether phospholipids in rat peripheral blood lymphocytes.

Etienne J, Rybkine T, Béréziat G, Polonovski J.

Thromb Res. 1987 Sep 1;47(5):573-83.

PMID:
3118499

Supplemental Content

Loading ...
Support Center